| pubmed-article:10760424 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10760424 | lifeskim:mentions | umls-concept:C0278996 | lld:lifeskim |
| pubmed-article:10760424 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:10760424 | lifeskim:mentions | umls-concept:C0144576 | lld:lifeskim |
| pubmed-article:10760424 | lifeskim:mentions | umls-concept:C0574032 | lld:lifeskim |
| pubmed-article:10760424 | lifeskim:mentions | umls-concept:C0920321 | lld:lifeskim |
| pubmed-article:10760424 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:10760424 | pubmed:dateCreated | 2000-7-31 | lld:pubmed |
| pubmed-article:10760424 | pubmed:abstractText | To determine the maximum tolerated dose (MTD) of paclitaxel given as a 96-hour continuous infusion during Weeks 1 and 5 of an accelerated radiotherapy schedule for the definitive treatment of advanced (nonmetastatic) unresectable squamous cell carcinoma of the head and neck (SCCHN). | lld:pubmed |
| pubmed-article:10760424 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10760424 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10760424 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10760424 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10760424 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10760424 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10760424 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10760424 | pubmed:month | May | lld:pubmed |
| pubmed-article:10760424 | pubmed:issn | 0360-3016 | lld:pubmed |
| pubmed-article:10760424 | pubmed:author | pubmed-author:KligermanM... | lld:pubmed |
| pubmed-article:10760424 | pubmed:author | pubmed-author:RosenthalD... | lld:pubmed |
| pubmed-article:10760424 | pubmed:author | pubmed-author:WeinsteinG... | lld:pubmed |
| pubmed-article:10760424 | pubmed:author | pubmed-author:WeberR SRS | lld:pubmed |
| pubmed-article:10760424 | pubmed:author | pubmed-author:TreatJJ | lld:pubmed |
| pubmed-article:10760424 | pubmed:author | pubmed-author:MintyC ACA | lld:pubmed |
| pubmed-article:10760424 | pubmed:author | pubmed-author:ChalianA AAA | lld:pubmed |
| pubmed-article:10760424 | pubmed:author | pubmed-author:MachtayMM | lld:pubmed |
| pubmed-article:10760424 | pubmed:author | pubmed-author:AvilesVV | lld:pubmed |
| pubmed-article:10760424 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10760424 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:10760424 | pubmed:volume | 44 | lld:pubmed |
| pubmed-article:10760424 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10760424 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10760424 | pubmed:pagination | 311-5 | lld:pubmed |
| pubmed-article:10760424 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10760424 | pubmed:meshHeading | pubmed-meshheading:10760424... | lld:pubmed |
| pubmed-article:10760424 | pubmed:meshHeading | pubmed-meshheading:10760424... | lld:pubmed |
| pubmed-article:10760424 | pubmed:meshHeading | pubmed-meshheading:10760424... | lld:pubmed |
| pubmed-article:10760424 | pubmed:meshHeading | pubmed-meshheading:10760424... | lld:pubmed |
| pubmed-article:10760424 | pubmed:meshHeading | pubmed-meshheading:10760424... | lld:pubmed |
| pubmed-article:10760424 | pubmed:meshHeading | pubmed-meshheading:10760424... | lld:pubmed |
| pubmed-article:10760424 | pubmed:meshHeading | pubmed-meshheading:10760424... | lld:pubmed |
| pubmed-article:10760424 | pubmed:meshHeading | pubmed-meshheading:10760424... | lld:pubmed |
| pubmed-article:10760424 | pubmed:meshHeading | pubmed-meshheading:10760424... | lld:pubmed |
| pubmed-article:10760424 | pubmed:meshHeading | pubmed-meshheading:10760424... | lld:pubmed |
| pubmed-article:10760424 | pubmed:meshHeading | pubmed-meshheading:10760424... | lld:pubmed |
| pubmed-article:10760424 | pubmed:meshHeading | pubmed-meshheading:10760424... | lld:pubmed |
| pubmed-article:10760424 | pubmed:meshHeading | pubmed-meshheading:10760424... | lld:pubmed |
| pubmed-article:10760424 | pubmed:meshHeading | pubmed-meshheading:10760424... | lld:pubmed |
| pubmed-article:10760424 | pubmed:meshHeading | pubmed-meshheading:10760424... | lld:pubmed |
| pubmed-article:10760424 | pubmed:meshHeading | pubmed-meshheading:10760424... | lld:pubmed |
| pubmed-article:10760424 | pubmed:meshHeading | pubmed-meshheading:10760424... | lld:pubmed |
| pubmed-article:10760424 | pubmed:meshHeading | pubmed-meshheading:10760424... | lld:pubmed |
| pubmed-article:10760424 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10760424 | pubmed:articleTitle | A phase I trial of 96-hour paclitaxel infusion plus accelerated radiotherapy of unrespectable head and neck cancer. | lld:pubmed |
| pubmed-article:10760424 | pubmed:affiliation | Department of Radiation Oncology, University of Pennsylvania, Philadelphia 19104, USA. machtay@xrt.upenn.edu | lld:pubmed |
| pubmed-article:10760424 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10760424 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10760424 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:10760424 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
